Sugi Predict

Sugi Predict / Compounds / SCHEMBL992973

SCHEMBL992973

SCHEMBL992973

CC(CO)c1ccccc1[N+](=O)[O-]

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.53
▸ CYP1A2 P05177 2/20 0.51
▸ TSHR P16473 2/20 0.51
▸ HSD17B10 Q99714 1/20 0.46
▸ TDP1 Q9NUW8 3/20 0.43
▸ GPR35 Q9HC97 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ POLB P06746 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ SLC6A2 P23975 1/20 0.41
▸ SLC6A4 P31645 1/20 0.41
▸ SLC6A3 Q01959 1/20 0.41
▸ KCNH2 Q12809 1/20 0.41
▸ CA1 P00915 1/20 0.41
▸ CA2 P00918 1/20 0.41
▸ MMP1 P03956 1/20 0.41
▸ MMP2 P08253 1/20 0.41
▸ MMP9 P14780 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29695357 1.00 ALDH1A1 (0.53) ALDH1A1CYP1A2TSHRHSD17B10TDP1
SCHEMBL6680488 0.84 ALDH1A1 (0.50) ALDH1A1CYP1A2TSHRHSD17B10TDP1
SCHEMBL3323932 0.84 ALDH1A1 (0.50) ALDH1A1CYP1A2TSHRHSD17B10TDP1
SCHEMBL5583971 0.82 ALDH1A1 (0.47) ALDH1A1CYP1A2TSHRHSD17B10TDP1
SCHEMBL23861299 0.82 ALDH1A1 (0.49) ALDH1A1CYP1A2TSHRHSD17B10TDP1
SCHEMBL11254195 0.82 CYP1A2 (0.50) ALDH1A1CYP1A2TSHRHSD17B10TDP1
SCHEMBL16674748 0.82 ALDH1A1 (0.49) ALDH1A1CYP1A2TSHRHSD17B10TDP1
SCHEMBL7777994 0.82 ALDH1A1 (0.50) ALDH1A1CYP1A2TSHRHSD17B10TDP1
SCHEMBL2941917 0.81 CYP1A2 (0.54) ALDH1A1CYP1A2TSHRHSD17B10TDP1
SCHEMBL29834848 0.81 CYP1A2 (0.54) ALDH1A1CYP1A2TSHRHSD17B10TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4703409-A1 LIGHT-RESPONSIVE CELL DESIGNER MOLECULE The University of Osaka (JP) 2026-03-04 — — EP claimed
WO-2024225384-A1 LIGHT-RESPONSIVE CELL DESIGNER MOLECULE 国立大学法人大阪大学 2024-10-31 — — WO claimed
CN-105968016-A Carbonic ester type photosensitive reagent and preparation method thereof as well as preparation method of 5'-photolabile dN 石平 2016-09-28 — — CN claimed
CN-104628574-A Carbonate photosensitive reagent, preparation method thereof and preparation method of 5' -photosensitive protection nucleoside SHI PING 2015-05-20 — — CN claimed
US-20100137600-A1 Photogenerated reagents LC SCIENCES LC 2010-06-03 — — US claimed
US-6965040-B1 Photogenerated reagents Gao, Xiaolian (US) 2005-11-15 — — US claimed
US-20050101763-A1 Synthesis of photolabile 2-(2-nitrophenyl)propyloxycarbonyl protected amino acids TRUSTEES OF BOSTON UNIVERSITY (US) 2005-05-12 — — US claimed
EP-4703409-A1 LIGHT-RESPONSIVE CELL DESIGNER MOLECULE The University of Osaka (JP) 2026-03-04 — — EP disclosed
WO-2024225384-A1 LIGHT-RESPONSIVE CELL DESIGNER MOLECULE 国立大学法人大阪大学 2024-10-31 — — WO disclosed
US-20230119934-A1 NETWORK POLYMERS AND METHODS OF MAKING AND USING SAME UNIV COLORADO REGENTS (US) 2023-04-20 — — US disclosed
US-11535713-B2 Network polymers and methods of making and using same THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2022-12-27 — — US disclosed
EP-3423499-B1 PHOTOCURABLE ELECTRON DEFICIENT OLEFIN-CONTAINING COMPOSITIONS Henkel IP & Holding GmbH (DE) 2022-06-01 — — EP disclosed
US-20210292482-A1 NETWORK POLYMERS AND METHODS OF MAKING AND USING SAME THE REGENTS OF THE UNIV OF COLORADO A BODY CORPORTATE (US) 2021-09-23 — — US disclosed
WO-2000061594-A2 NUCLEOSIDE DERIVATIVES WITH PHOTO-UNSTABLE PROTECTIVE GROUPS Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) 2000-10-19 — — WO disclosed
EP-0901501-A1 NUCLEOSIDE DERIVATIVES WITH PHOTO-UNSTABLE PROTECTIVE GROUPS Pfleiderer, Wolfgang (DE) 1999-03-17 — — EP disclosed
US-5763599-A FOR LIGHT-CONTROLLED SYNTHESIS OF OLIGONUCLEOTIDES ON DNA CHIP Pfleiderer, Wolfgang (DE) 1998-06-09 — — US disclosed
WO-1997044345-A1 NUCLEOSIDE DERIVATIVES WITH PHOTO-UNSTABLE PROTECTIVE GROUPS PFLEIDERER WOLFGANG (DE) 1997-11-27 — — WO disclosed
EP-0797580-A2 NUCLEOSIDE DERIVATIVES WITH PHOTOLABILE PROTECTIVE GROUPS Pfleiderer, Wolfgang (DE) 1997-10-01 — — EP disclosed
WO-1996018634-A2 NUCLEOSIDE DERIVATIVES WITH PHOTOLABILE PROTECTIVE GROUPS PFLEIDERER WOLFGANG (DE) 1996-06-20 — — WO disclosed
US-4333930-A TREATMENT OF CENTRAL NERVOUS DISORDERS, ANALGESICS, ANTIDEPRESSANTS LABORATOIRES SARGET (FR) 1982-06-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050101763-A1 Synthesis of photolabile 2-(2-nitrophenyl)propyloxycarbonyl protected amino acids NPPA, DNPEP, NPEPPS ALDH1A1 4813/4885CYP1A2 4303/4885TSHR 3415/4885
US-20100137600-A1 Photogenerated reagents PPOX, PGR, GRHPR ALDH1A1 1813/4885CYP1A2 221/4885TSHR 446/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.